Literature DB >> 11577904

Conditioned inhibition of fear-potentiated startle and skin conductance in humans.

C Grillon1, R Ameli.   

Abstract

Conditioned inhibition of classical conditioning was investigated with the startle reflex and the skin conductance response (SCR) in humans using a serial presentation of the conditioned inhibitor (X) and of the conditioned stimulus (CS). The unconditioned stimulus (US) was a shock. During conditioning, participants were presented with two different reinforced CS (A, B) and with X preceding A (noted X-->A). During X-->A, A was not reinforced with the US. During the summation test, B, X-->B, and Y-->B were presented (Y was a new stimulus that tested the specificity of the inhibitory properties of X). B was not reinforced during the summation test. A, B, X, and Y were lights of different colors. Participants were divided into a low and a high anxious group based on the TPQ (C.R. Cloninger, 1987). In the low anxious group, conditioned startle potentiation and SCR responses to A were inhibited when X preceded A (noted A(XA)). This differential responding to A and A(XA) emerged earlier with the SCR than with startle. During the summation test, the inhibitory properties of X did not transfer to B. In the high anxious group, there was only a differential SCR to A and A(XA). X did not inhibit startle potentiation to A.

Entities:  

Mesh:

Year:  2001        PMID: 11577904

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  23 in total

Review 1.  Impaired safety signal learning may be a biomarker of PTSD.

Authors:  Tanja Jovanovic; Andrew Kazama; Jocelyne Bachevalier; Michael Davis
Journal:  Neuropharmacology       Date:  2011-03-04       Impact factor: 5.250

Review 2.  Dispositional negativity: An integrative psychological and neurobiological perspective.

Authors:  Alexander J Shackman; Do P M Tromp; Melissa D Stockbridge; Claire M Kaplan; Rachael M Tillman; Andrew S Fox
Journal:  Psychol Bull       Date:  2016-10-10       Impact factor: 17.737

3.  Controllability modulates the neural response to predictable but not unpredictable threat in humans.

Authors:  Kimberly H Wood; Muriah D Wheelock; Joshua R Shumen; Kenton H Bowen; Lawrence W Ver Hoef; David C Knight
Journal:  Neuroimage       Date:  2015-07-03       Impact factor: 6.556

Review 4.  On the basis of sex: Differences in safety discrimination vs. conditioned inhibition.

Authors:  Jamie N Krueger; Susan Sangha
Journal:  Behav Brain Res       Date:  2020-12-05       Impact factor: 3.332

5.  How many blinks are necessary for a reliable startle response? A test using the NPU-threat task.

Authors:  Lynne Lieberman; Elizabeth S Stevens; Carter J Funkhouser; Anna Weinberg; Casey Sarapas; Ashley A Huggins; Stewart A Shankman
Journal:  Int J Psychophysiol       Date:  2017-02-02       Impact factor: 2.997

6.  Using a cultural and RDoC framework to conceptualize anxiety in Asian Americans.

Authors:  Huiting Liu; Lynne Lieberman; Elizabeth S Stevens; Randy P Auerbach; Stewart A Shankman
Journal:  J Anxiety Disord       Date:  2016-09-17

7.  Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity.

Authors:  Tanja Jovanovic; Seth D Norrholm; Jennifer E Fennell; Megan Keyes; Ana M Fiallos; Karyn M Myers; Michael Davis; Erica J Duncan
Journal:  Psychiatry Res       Date:  2009-04-05       Impact factor: 3.222

8.  Affective modulation of the startle eyeblink and postauricular reflexes in autism spectrum disorder.

Authors:  Gabriel S Dichter; Stephen D Benning; Tia N Holtzclaw; James W Bodfish
Journal:  J Autism Dev Disord       Date:  2010-07

9.  The chronometry of affective startle modulation in unipolar depression.

Authors:  Gabriel S Dichter; Andrew J Tomarken
Journal:  J Abnorm Psychol       Date:  2008-02

Review 10.  How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD.

Authors:  Tanja Jovanovic; Kerry J Ressler
Journal:  Am J Psychiatry       Date:  2010-03-15       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.